Initiation of cholinesterase inhibitors in an inpatient setting

Kamal Wagle, Paul J. Rowan, Oi Yee Ivy Poon, Mark E. Kunik, George E. Taffet, Ursula K. Braun

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

We examined initiation of cholinesterase inhibitors (ChEIs) to determine whether ChEIs were being newly prescribed without sufficient evaluation for dementia and/or delirium and to explore whether there are differences in outcomes, such as mortality, hospital readmission rates, and duration of hospitalization, between patients newly started on ChEI and those who continued such medications prior to admission. Patients hospitalized in fiscal year 2008 and prescribed ChEI were identified. We reviewed electronic medical records. Of 282 patients, 15.6% (44) were new-starts and 84.4% (238) were continuations. Median length of stay was 16 days in new-starts versus 6 days in continuations (P <.05). Of new-starts, 38.6% were also treated of infection. Chart review additionally suggested possible treatment of delirium by initiation of benzodiazepines and antipsychotics in 11.4% and 22.7% of new-starts, respectively. We observed a substantive practice of initiating ChEIs in hospitalized elderly patients at risk of delirium. Although there was no difference in the 30-day mortality or readmission rates, new-starts were more likely to have a longer hospital stay than continuation patients.

Original languageEnglish (US)
Pages (from-to)377-383
Number of pages7
JournalAmerican Journal of Alzheimer's Disease and other Dementias
Volume28
Issue number4
DOIs
StatePublished - Jun 2013
Externally publishedYes

Fingerprint

Cholinesterase Inhibitors
Inpatients
Delirium
Length of Stay
Patient Readmission
Mortality
Electronic Health Records
Benzodiazepines
Antipsychotic Agents
Dementia
Hospitalization
Infection

Keywords

  • cholinesterase inhibitors
  • dementia
  • inpatients
  • medical record review
  • veterans

ASJC Scopus subject areas

  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Initiation of cholinesterase inhibitors in an inpatient setting. / Wagle, Kamal; Rowan, Paul J.; Poon, Oi Yee Ivy; Kunik, Mark E.; Taffet, George E.; Braun, Ursula K.

In: American Journal of Alzheimer's Disease and other Dementias, Vol. 28, No. 4, 06.2013, p. 377-383.

Research output: Contribution to journalReview article

Wagle, Kamal ; Rowan, Paul J. ; Poon, Oi Yee Ivy ; Kunik, Mark E. ; Taffet, George E. ; Braun, Ursula K. / Initiation of cholinesterase inhibitors in an inpatient setting. In: American Journal of Alzheimer's Disease and other Dementias. 2013 ; Vol. 28, No. 4. pp. 377-383.
@article{f171c371380b4714862f7b5a7fb63c2c,
title = "Initiation of cholinesterase inhibitors in an inpatient setting",
abstract = "We examined initiation of cholinesterase inhibitors (ChEIs) to determine whether ChEIs were being newly prescribed without sufficient evaluation for dementia and/or delirium and to explore whether there are differences in outcomes, such as mortality, hospital readmission rates, and duration of hospitalization, between patients newly started on ChEI and those who continued such medications prior to admission. Patients hospitalized in fiscal year 2008 and prescribed ChEI were identified. We reviewed electronic medical records. Of 282 patients, 15.6{\%} (44) were new-starts and 84.4{\%} (238) were continuations. Median length of stay was 16 days in new-starts versus 6 days in continuations (P <.05). Of new-starts, 38.6{\%} were also treated of infection. Chart review additionally suggested possible treatment of delirium by initiation of benzodiazepines and antipsychotics in 11.4{\%} and 22.7{\%} of new-starts, respectively. We observed a substantive practice of initiating ChEIs in hospitalized elderly patients at risk of delirium. Although there was no difference in the 30-day mortality or readmission rates, new-starts were more likely to have a longer hospital stay than continuation patients.",
keywords = "cholinesterase inhibitors, dementia, inpatients, medical record review, veterans",
author = "Kamal Wagle and Rowan, {Paul J.} and Poon, {Oi Yee Ivy} and Kunik, {Mark E.} and Taffet, {George E.} and Braun, {Ursula K.}",
year = "2013",
month = "6",
doi = "10.1177/1533317513488909",
language = "English (US)",
volume = "28",
pages = "377--383",
journal = "American Journal of Alzheimer's Disease and other Dementias",
issn = "1533-3175",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Initiation of cholinesterase inhibitors in an inpatient setting

AU - Wagle, Kamal

AU - Rowan, Paul J.

AU - Poon, Oi Yee Ivy

AU - Kunik, Mark E.

AU - Taffet, George E.

AU - Braun, Ursula K.

PY - 2013/6

Y1 - 2013/6

N2 - We examined initiation of cholinesterase inhibitors (ChEIs) to determine whether ChEIs were being newly prescribed without sufficient evaluation for dementia and/or delirium and to explore whether there are differences in outcomes, such as mortality, hospital readmission rates, and duration of hospitalization, between patients newly started on ChEI and those who continued such medications prior to admission. Patients hospitalized in fiscal year 2008 and prescribed ChEI were identified. We reviewed electronic medical records. Of 282 patients, 15.6% (44) were new-starts and 84.4% (238) were continuations. Median length of stay was 16 days in new-starts versus 6 days in continuations (P <.05). Of new-starts, 38.6% were also treated of infection. Chart review additionally suggested possible treatment of delirium by initiation of benzodiazepines and antipsychotics in 11.4% and 22.7% of new-starts, respectively. We observed a substantive practice of initiating ChEIs in hospitalized elderly patients at risk of delirium. Although there was no difference in the 30-day mortality or readmission rates, new-starts were more likely to have a longer hospital stay than continuation patients.

AB - We examined initiation of cholinesterase inhibitors (ChEIs) to determine whether ChEIs were being newly prescribed without sufficient evaluation for dementia and/or delirium and to explore whether there are differences in outcomes, such as mortality, hospital readmission rates, and duration of hospitalization, between patients newly started on ChEI and those who continued such medications prior to admission. Patients hospitalized in fiscal year 2008 and prescribed ChEI were identified. We reviewed electronic medical records. Of 282 patients, 15.6% (44) were new-starts and 84.4% (238) were continuations. Median length of stay was 16 days in new-starts versus 6 days in continuations (P <.05). Of new-starts, 38.6% were also treated of infection. Chart review additionally suggested possible treatment of delirium by initiation of benzodiazepines and antipsychotics in 11.4% and 22.7% of new-starts, respectively. We observed a substantive practice of initiating ChEIs in hospitalized elderly patients at risk of delirium. Although there was no difference in the 30-day mortality or readmission rates, new-starts were more likely to have a longer hospital stay than continuation patients.

KW - cholinesterase inhibitors

KW - dementia

KW - inpatients

KW - medical record review

KW - veterans

UR - http://www.scopus.com/inward/record.url?scp=84879723123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879723123&partnerID=8YFLogxK

U2 - 10.1177/1533317513488909

DO - 10.1177/1533317513488909

M3 - Review article

C2 - 23702586

AN - SCOPUS:84879723123

VL - 28

SP - 377

EP - 383

JO - American Journal of Alzheimer's Disease and other Dementias

JF - American Journal of Alzheimer's Disease and other Dementias

SN - 1533-3175

IS - 4

ER -